Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Long-Term Investments (2023 - 2025)

BrightSpring Health Services' Long-Term Investments history spans 3 years, with the latest figure at $4.7 million for Q4 2025.

  • For Q4 2025, Long-Term Investments rose 229.5% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, up 229.5%, while the annual FY2025 figure was $4.7 million, 229.5% up from the prior year.
  • Long-Term Investments reached $4.7 million in Q4 2025 per BTSG's latest filing, up from $4.5 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $4.7 million in Q4 2025 to a low of $650000.0 in Q1 2025.
  • Average Long-Term Investments over 3 years is $1.7 million, with a median of $720000.0 recorded in 2023.
  • The largest YoY upside for Long-Term Investments was 567.41% in 2025 against a maximum downside of 5.66% in 2025.
  • A 3-year view of Long-Term Investments shows it stood at $720000.0 in 2023, then soared by 98.19% to $1.4 million in 2024, then soared by 229.5% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Long-Term Investments are $4.7 million (Q4 2025), $4.5 million (Q3 2025), and $970000.0 (Q2 2025).